BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Coimbra S, Santos-Silva A. Biomarkers of psoriasis severity and therapy monitoring. World J Dermatol 2014; 3(2): 15-27 [DOI: 10.5314/wjd.v3.i2.15]
URL: https://www.wjgnet.com/2218-6190/full/v3/i2/15.htm
Number Citing Articles
1
Katerina Kondelkova, Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Simona Rendarova, Vit Rehacek, Jan Kremlacek, Zdenek Fiala. Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman TherapyMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/979526
2
Drahomira Holmannova, Pavel Borsky, Lenka Borska, Ctirad Andrys, Kvetoslava Hamakova, Vit Rehacek, Tereza Svadlakova, Andrea Malkova, Martin Beranek, Vladimir Palicka, Jan Krejsek, Zdenek Fiala. Metabolic Syndrome, Clusterin and Elafin in Patients with Psoriasis VulgarisInternational Journal of Molecular Sciences 2020; 21(16): 5617 doi: 10.3390/ijms21165617
3
Ziwen Sun, Xiaomin Shi, Yun Wang, Yi Zhao. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease SeverityDermatology 2018; 234(3-4): 120 doi: 10.1159/000488672
4
Ilinca Nicolae, Mircea Tampa, Corina Ene, Cristina Mitran, Madalina Mitran, Maria Sarbu, Clara Matei, Cosmin Ene, Simona Georgescu. Correlations between related-purine derivatives and renal disorders in patients with psoriasis vulgarisExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.7053
5
Brittany Sismour, Kristin D'Acunto. Down syndrome, severe psoriasis, and increased risk for cardiovascular eventsJournal of the American Academy of Physician Assistants 2019; 32(12): 31 doi: 10.1097/01.JAA.0000604860.71819.c1